BK
66
3
ADSK
70
-4
EQT
25
6
YUM
52
9
NI
67
4
HOG
33
2
AFL
64
2
DVN
25
7
ALLE
35
10
PNW
45
-4
LRCX
71
-6
INTC
41
-6
PSX
39
2
MNST
59
3
NWSA
84
6
FRT
45
6
AEE
50
4
RRC
52
6
HES
67
5
MMM
33
3
BK
66
3
ADSK
70
-4
EQT
25
6
YUM
52
9
NI
67
4
HOG
33
2
AFL
64
2
DVN
25
7
ALLE
35
10
PNW
45
-4
LRCX
71
-6
INTC
41
-6
PSX
39
2
MNST
59
3
NWSA
84
6
FRT
45
6
AEE
50
4
RRC
52
6
HES
67
5
MMM
33
3
Financhill
Back

Castle Biosciences Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
50

CSTL
Castle Biosciences

Last Price:
21.50
Seasonality Move:
14.81%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
50
Castle Biosciences (CSTL) is a Sell

Is Castle Biosciences a Buy, Sell or Hold?

  • The current Castle Biosciences [CSTL] share price is $21.44. The Score for CSTL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CSTL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CSTL Stock Price Chart

What is Castle Biosciences's stock price today?

  • The Castle Biosciences share price today is $21.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CSTL is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

CSTL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 41.35 Sell
Chaikin Money Flow: -225807 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.09 - 24.31) Sell
Bollinger Bands (100): (20.36 - 24.18) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CSTL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.07 Sell
20-day SMA: 22.88 Sell
50-day SMA: 22.56 Sell
200-day SMA: 20.26 Buy
8-day EMA: 21.99 Sell
20-day EMA: 22.58 Sell
50-day EMA: 22.59 Sell
200-day EMA: 21.38 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

Castle Biosciences Earnings Growth & CSTL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.11 per share, an increase this year of $0.95 per share, and a decrease next year of $0.33 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Castle Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):